Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 51 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 7960606

    Mouse model of chronic heart failure and coronary atherosclerosis regression

    The Regents of the University of California · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  2. US 7951770

    Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process

    Northwestern University · Granted May 31, 2011 · Expires May 26, 2031

    granted

  3. US 7947737

    Method of treating hypertension and reducing serum lipase activity

    Aker Biomarine AS · Granted May 24, 2011 · Expires May 19, 2031

    granted

  4. US 7923014

    Expression and purification of HIP/PAP and uses therefor

    The Board of Regents of the University of Texas System · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  5. US 7919466

    Lymphatic zip codes in tumors and pre-malignant lesions

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  6. US 7914801

    Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  7. US 7915040

    Defensin-antigen fusion proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  8. US 7902235

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  9. US 7902168

    Compositions and methods for inhibiting expression of Nav1.8 gene

    Alnylam Pharmaceuticals, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  10. US 7902241

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  11. US 7897152

    Viral chemokine-antigen fusion proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 1, 2011 · Expires Feb 24, 2031

    granted

  12. US 7892786

    Methods for expression and purification of immunotoxins

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  13. US 7892008

    Electrical connector having metallic lock

    Hon Hai Precision Ind. Co., Ltd. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  14. US 7888498

    Compositions and methods for inhibiting expression of IKK-B gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  15. US 7879334

    Fusion molecules and treatment of IgE-mediated allergic diseases

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  16. US 7879324

    Fusion molecules and methods for treatment of immune diseases

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  17. US 7875711

    Compositions and methods for inhibiting expression of XBP-1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  18. US 7875622

    Methods and compositions for treating pulmonary hypertension and related diseases and disorders

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  19. US 7875262

    Aqueous starch-oil dispersions having improved UV stability and absorbing ability

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  20. US 7871985

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  21. US 7868160

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Pharmaceuticals, Inc. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  22. US 7846907

    Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted

  23. US 7837999

    Method of increasing muscle mass with IGF-1 fusion polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  24. US 7829693

    Compositions and methods for inhibiting expression of a target gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.